ZFIN Image: Barrodia et al., 2018, Fig. S5

Image

Figure Caption

Fig. S5 Role of RA and Efhc2 in pronephros segmentation. Wild-type embryos or efhc2-Mo morphants were treated with DMSO, RA and DEAB. WISH showing expression of slc12a1 (DE), slc12a3 (DL), stc1 (CS) and odf3 (MCC). efhc2-Mo morphants treated with RA show expansion of expression domain of DE marker slc12a1 and almost or complete loss of DL and CS markers slc12a3 and stc1 as compared with wild-type embryos treated with RA. The expression domain and the number of cells expressing MCC maker odf3 was partially rescued by RA treatment in the morphants. DEAB treated efhc2-Mo morphants show expansion of DE, DL, and CS as compared with wild-type embryos treated with DEAB. The expression domain of odf3 is reduced in DEAB treated WT embryos.

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Cell Biosci.